Geovax Labs Inc (NAS:GOVXW)
$ 0.0599 -0.0001 (-0.17%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 75.65 GF Score: 47/100

GeoVax Labs Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 01:00AM GMT
Unidentified Participant

And welcome to our last presentation for the day, GeoVax Labs from Smyrna, Georgia. GeoVax is focused on immuno-oncology vaccines. And presenting for the Company is their Chairman and CEO, David Dodd.

David Dodd
GeoVax Labs, Inc. - Chairman, President & CEO

Thank you, Tony. First, [man], I mean I was thinking Tony La Russa. And I said, you've got a famous name there, but it's Tony Russo. Anyway, it isn't, I wish [were]. Anyway, thank you.

So if you have your phones onto the game, silence them. And if you're not aware that there's a game, University of Georgia is playing TCU. And we have some people here upset that we're here rather than in a bar watching their Bulldogs.

But anyway, thank you for being here. It's a pleasure to tell you about GeoVax. And again, I'll probably get through with this. And so, if you have questions outside, we can talk about them whatever, like to.

So indeed, we are a clinical-stage program. We're in Phase 2 clinical, we're developing both immunotherapies in oncology as well as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot